Xenon Pharmaceuticals: Q4 Earnings Snapshot
Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise
Xenon Pharmaceuticals: Q3 Earnings Snapshot
Xenon Pharmaceuticals: Q2 Earnings Snapshot
Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -1.61% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Xenon Pharmaceuticals: Q1 Earnings Snapshot
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sutro Biopharma, Inc. (STRO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...
Incyte (INCY) delivered earnings and revenue surprises of -56.47% and 7.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of 1.72% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?